T cell biomarker predicts which CLL patients will respond to CAR T cell therapy – EurekAlert (press release)
EurekAlert (press release) |
T cell biomarker predicts which CLL patients will respond to CAR T cell therapy
EurekAlert (press release) PHILADELPHIA – Penn Medicine researchers may have found the reason why some patients with advanced chronic lymphocytic leukemia (CLL) don't respond to chimeric antigen receptor (CAR) T cell therapy, and the answer is tied to how primed patients' immune … |
